Ask Questions, Get Industry Insights … Instantly

Save time and get answers to complex questions with AI chat

Recent Questions

Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
Mobic injection patent oehringer ingelheim france?
Patent expiration date of guselkumab?
Generic brand for latisse?
When oxcarbazepine patent expired?

Acalabrutinib fda approval date calquence 2017?

See the DrugPatentWatch profile for Acalabrutinib

Yes. Calquence (acalabrutinib) was approved by the FDA on November 29, 2017, for adults with mantle cell lymphoma who have received at least one prior therapy.

Other Questions About Acalabrutinib :

Acalabrutinib fda approval october 2017 calquence? Acalabrutinib fda approval date october 31 2017? Acalabrutinib fda approval october 2017? Acalabrutinib market? Acalabrutinib fda approval date 2017? Acalabrutinib fda approval cll? Acalabrutinib patent expire?